Core Viewpoint - Zhongchong Co., Ltd. (002891.SZ) has received an administrative regulatory measure from the Shandong Securities Regulatory Bureau due to a failure to disclose a change in shareholding percentage following a convertible bond conversion, which resulted in a decrease from 26.08% to 25.94% [1] Group 1: Regulatory Actions - The Shandong Securities Regulatory Bureau issued a decision requiring Zhongchong to correct its actions and engage in regulatory discussions due to non-compliance with the disclosure requirements of the Securities and Futures Law [1] - Zhongchong is advised to enhance its understanding of securities laws and improve its operational standards and information disclosure quality to prevent future violations [1] Group 2: Shareholding Changes - On April 29, 2025, the shareholding of Zhongchong's controlling shareholder, Yantai Zhongxing Biotechnology Co., Ltd., and its concerted action party, Shanghai Tongyi Investment Management Co., Ltd., decreased due to the conversion of convertible bonds [1] - The reduction in shareholding percentage triggered a requirement for disclosure, which Zhongchong failed to meet, leading to regulatory scrutiny [1] Group 3: Share Reduction Plans - On July 16, 2025, Zhongchong announced a pre-disclosure regarding the share reduction plan by its concerted action party, which intends to reduce its holdings by up to 4.56 million shares (1.50% of total share capital) within a specified period [2] - The controlling shareholder of Zhongchong is Yantai Zhongxing, with actual controllers being Hao Zhongli and Xiao Ailing [2] Group 4: Fundraising Activities - Zhongchong has conducted multiple fundraising activities, including issuing convertible bonds and non-public offerings, with total funds raised amounting to approximately 2 billion yuan [6] - The company has consistently engaged in fundraising through various financial instruments, demonstrating its active capital management strategy [6]
中宠股份收监管措施 实控人方减持中A股4募资共20亿